ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today reported results for the second quarter of 2007. Second Quarter 2007 vs. 2006 Highlights: * Revenues totaled $231.0 million, compared to $230.4 million.
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today reported results for the second quarter of 2007. Second Quarter 2007 vs. 2006 Highlights: * Revenues totaled $231.0 million, compared to $230.4 million.
